Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytomegalovirus resistance in CD34+ -selected hematopoietic cell transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society - 1 Jun 2018

Kim Seong Jin, Huang Yao-Ting, Foldi Julia, Lee Yeon Joo, Maloy Molly, Giralt Sergio A, Jakubowski Ann A, Papanicolaou Genovefa A

Abstract excerpt

BACKGROUND: Cytomegalovirus (CMV) viremia after CD34+ -selected hematopoietic stem cell transplant (HCT) often requires prolonged antiviral therapy. We report rates and outcomes of resistant CMV in a contemporary cohort of CD34+ -selected HCT recipients managed preemptively. METHODS: We retrospectively reviewed 220 consecutive, CMV-seropositive recipients (R+), who received CD34+ -selected HCT at Memorial Sloan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Cytomegalovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytomegalovirus Infections

Share to DNA-Directed DNA Polymerase

Share to Hematopoietic Stem Cell Transplantation

Share to Transplant Recipients

Share to Viral Proteins

Share to Viremia

Source

Open in PubMed Open full text

Identifiers

PMID: 29570237
DOI: 10.1111/tid.12881
PMCID: PMC5988949

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytomegalovirus resistance in CD34+ -selected hematopoietic cell transplant recipients.PMID 29570237Read ↗

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.Semantic proximity Read ↗

Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.Semantic proximity Read ↗

Study of cytomegalovirus resistance in allogeneic hematopoietic cell transplant recipients.Semantic proximity Read ↗

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.Semantic proximity Read ↗

The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.Semantic proximity Read ↗

Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.Semantic proximity Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.Semantic proximity Read ↗

Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.Semantic proximity Read ↗

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.Semantic proximity Read ↗

Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.Semantic proximity Read ↗

[Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.